To explore this, we used a previously established MCM2-deficient mouse model of cancer, generated by integration of a tamoxifen-inducible form of Cre recombinase downstream of the Mcm2 coding sequence and expression via an internal ribosome entry site (IRES) [35]. This evidence concerns the gene MCM2 and cancer.